Join for Free!
121578 members

Clinical trial: Morpholinos for Duchenne molecular dystrophy

Human Anatomy, Physiology, and Medicine. Anything human!

Moderator: BioTeam

Clinical trial: Morpholinos for Duchenne molecular dystrophy

Postby jonmoulton » Tue Feb 17, 2009 11:58 pm

AVI BioPharma has started a clinical trial involving systemic administration of their AVI-4658 Morpholino oligo targeted to modify splicing of exon 51 in the human Dystrophin pre-mRNA transcript, excluding exon 51 from the mature mRNA. This is an experimental therapeutic for some mutations causing Duchenne muscular dystrophy, designed to restore the reading frame and ameliorate the effects of a frame-shifting mutation. This study involves intravenous injection of an unmodified Morpholino (note: Morpholinos are also called PMO, an acronym for phosphorodiamidate Morpholino oligomer).


ClinicalTrials.gov identifier: NCT00844597
User avatar
Posts: 441
Joined: Fri Feb 15, 2008 5:38 pm
Location: Philomath, Oregon, USA

Postby MrMistery » Fri Feb 20, 2009 12:16 am

this is pretty interesting... if this technology does prove effective in this kind of approach, a large number of genetic diseases could be theoretically treated with such morpholino-based drugs.
"As a biologist, I firmly believe that when you're dead, you're dead. Except for what you live behind in history. That's the only afterlife" - J. Craig Venter
User avatar
Inland Taipan
Inland Taipan
Posts: 6832
Joined: Thu Mar 03, 2005 10:18 pm
Location: Romania(small and unimportant country)

Return to Human Biology

Who is online

Users browsing this forum: No registered users and 1 guest